Drug Discovery · South San Francisco, CA · Founded 2022 · Privately Held (backing)
Operator of a biotech company intended to combine data to find better targets and drugs that can treat patients. Tahoe is based in South San Francisco, CA and was founded in 2022. It was valued at $131 million at its early-stage round in Aug 2025, the last priced event on record. It has raised $50 million across 1 recorded round; the latest was a $35 million Series A in Aug 2025.
PMV mark · valuation
$131.0M
Oct 2026
Priced at
its early-stage round
Aug 2025
Total raised
$50.0M
Last round
Early Stage VC (Series A)
Aug 2025
Team — not yet on record
No current team members for Tahoe are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Tahoe with a free account
·The complete investor list: 12 names
·Watch Tahoe: the Monday email on marks, rounds and moves
